Hims (HIMS): FY24 Q4 earnings call, Feb 24, 2025

Mon, Feb 24Earnings callSpeaker-labelled transcriptHims

No Kalshi or Polymarket word markets were listed for Hims’s Feb 24, 2025 earnings call (FY24 Q4). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

4 matches for “Vitamin”; 4 quoted, at least 25 words apart.

Andrew Dudumcompanyprepared

…support high quality clinical outcomes through optimized dosing, side effects mitigation, and vitamin supplementation. And we've broadened our brand from one that's focused on niche…

Andrew Dudumcompanyprepared

…datasets enable us to identify elements of a member's health such as vitamin deficiencies and unoptimized health indicators leading to better personalization of treatment through…

Andrew Dudumcompanyprepared

…variations. And this is hyper-personalization across dosing, side effect mitigation, multi-condition support, vitamin supplementation, and ultimately, form factor, which we know has a massive…

Andrew Dudumcompanyqa

…[indiscernible]. And that's going to really unlock not only more precise treatments, vitamin supplementation, but also, I think, multi-condition treatments because you're able to really…

Agents: this page as TSV at /api/v1/appearances/hims:2025-02-24:earnings_call · words: /api/v1/brief?appearance=hims:2025-02-24:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP